先天性心脏病手术中术中与出院前残余病变严重程度的比较
单中心回顾性研究纳入2011年1月至2019年12月连续6201例先天性心脏病手术患者,分别用术中超声和出院前超声评定术中技术性能评分(IO-TPS)和出院前技术性能评分(DC-TPS)。IO-TPS与DC-TPS总体一致率68.6%,出院时评分更可能变差(P<.001)。IO-TPS与DC-TPS均为质量改进的重要辅助工具。
要点
- IO-TPS与DC-TPS总体一致率68.6%,出院时评分更可能变差(P<.001)
- 房室瓣和半月瓣至少2级残余病变患者中,IO-TPS更可能恶化而非改善(均P<.001)
- 3级患者院内/早期死亡、出院后/晚期死亡和晚期非计划再干预风险均高于1级(均P<.05)
核心结论
- IO-TPS和DC-TPS均为先天性心脏病手术质量改进的重要辅助工具。
研究设计与样本
- 单中心回顾性研究,连续纳入2011年1月至2019年12月接受先天性心脏病手术的患者6201例。
- 分别用术中超声和出院前超声评定IO-TPS和DC-TPS(1级无残余病变,2级轻微残余病变,3级主要残余病变),并对所有2/3级患者分配识别主要残余病变的解剖模块。
主要发现
- 6201例患者中,IO-TPS与DC-TPS总体一致者4251例(68.6%),出院时评分更可能更差(P<.001)。
- 配对比较分析显示,房室瓣和半月瓣至少2级残余病变患者中,IO-TPS更可能恶化而非改善(均P<.001)。
- 3级患者较1级患者院内/早期死亡风险更高(IO-TPS:比值比7.5,95%CI 2.4-23;DC-TPS:比值比6.6,95%CI 3.0-15)。
- 3级患者较1级患者出院后/晚期死亡风险更高(IO-TPS:风险比3.1,95%CI 1.3-7.1;DC-TPS:风险比2.3,95%CI 1.2-4.4)。
- 3级患者较1级患者晚期非计划再干预风险更高(IO-TPS:风险比2.8,95%CI 1.9-4.0;DC-TPS:风险比3.4,95%CI 2.8-4.2)(均P<.05)。
关键数值与推荐
- IO-TPS与DC-TPS模型对早期和晚期死亡的预测拟合相当;DC-TPS模型对晚期再干预的预测拟合略优。
- IO-TPS与DC-TPS总体一致率68.6%(4251/6201),出院时评分更可能更差(P<.001)。
临床怎么用
- IO-TPS和DC-TPS均为先天性心脏病手术质量改进的重要辅助工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While the predischarge technical performance score (DC-TPS) is significantly associated with outcomes after congenital cardiac surgery, the utility of the intraoperative TPS (IO-TPS) remains unknown. METHODS: This was a single-center retrospective review of consecutive patients who underwent congenital cardiac surgery from January 2011 to December 2019. Intraoperative and predischarge echocardiograms were used to assign IO-TPS and DC-TPS, respectively, for each index operation (class 1, no residua; class 2, minor residua; class 3, major residua). Anatomic modules identifying the principal residual lesion were assigned to all class 2/3 patients. Overall and module-specific TPS comparisons were made. Multivariable regression models with IO-TPS and DC-TPS as separate predictors of postoperative outcomes were compared. RESULTS: Of 6201 patients, overall agreement between IO-TPS and DC-TPS was observed in 4251 patients (68.6%); scores were likelier to be worse at discharge (P < .001). Paired comparative analyses revealed that among patients with at least class 2 atrioventricular and semilunar valve residua, IO-TPS was likelier to worsen than improve (both P < .001). Class 3 patients had a higher risk of in-hospital/early mortality (IO-TPS: odds ratio, 7.5; 95% CI, 2.4-23; DC-TPS: odds ratio, 6.6; 95% CI, 3.0-15), postdischarge/late mortality (IO-TPS: hazard ratio [HR], 3.1, 95% CI, 1.3-7.1; DC-TPS: HR, 2.3; 95% CI, 1.2-4.4), and late unplanned reintervention (IO-TPS: HR, 2.8; 95% CI, 1.9-4.0; DC-TPS: HR, 3.4; 95% CI, 2.8-4.2) vs class 1 (all P < .05). IO- and DC-TPS models were equivalent fits for predicting early and late mortality; the latter was a marginally better fit for late reintervention. CONCLUSIONS: IO-TPS and DC-TPS are both important adjuncts for quality improvement in congenital cardiac surgery.
引用
- Sengupta A, Gauvreau K, Kohlsaat K, et al. Comparison of Intraoperative and Discharge Residual Lesion Severity in Congenital Heart Surgery. Ann Thorac Surg. 2022. PMID: 35398038. doi:10.1016/j.athoracsur.2022.02.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。